News

Money Morning7h
Eli Lilly (LLY): Should You Buy or Sell After Drug Price Order?
Eli Lilly (NYSE: LLY) was an unstoppable bet in the past few years, but LLY stock finally started plateauing in the latter ...
Jim Cramer on Eli Lilly and Company (LLY) – “Buy Hand Over Fist – This GLP-1 Giant Just Crushed Novo”
On Monday’s episode of Mad Money, Jim Cramer broke down the day’s market rally and argued in favor of staying invested, even ...
STAT9h
Eli Lilly and AstraZeneca top a consultancy’s ranking of drug company R&D
A consultancy’s new ranking of drug company R&D shows Eli Lilly has risen to the top of the drug development heap, while ...
President Trump Just Announced Terrible News for Eli Lilly Investors
Now, this won't come as too much of a surprise to Eli Lilly and its peers. A few weeks ago, the company's CEO, David Ricks, ...
Eli Lilly (NYSE:LLY) Announces Executive Changes To Drive Global Growth And Pipeline Advancement
Eli Lilly (NYSE:LLY) recently announced leadership transitions, including new roles for Ilya Yuffa, Patrik Jonsson, and ...
WFYI2d
Eli Lilly expands partnership with Purdue by $250 million
The Lilly announcement will extend an agreement aimed at accelerating medicine development and bolstering the ...
Explore more
Hoodline4d
Eli Lilly and Purdue University Forge $250 Million Alliance to Advance Pharmaceutical Innovation in Indiana
Eli Lilly and Purdue University expand their partnership with a $250 million investment to advance pharmaceutical innovation ...
Yahoo Finance3d
Eli Lilly and Company (LLY)
Eli Lilly and Company (NYSE: LLY) today announced detailed results from SURMOUNT-5, a Phase 3b open-label clinical trial, evaluating the safety and efficacy of Zepbound (tirzepatide), a dual GIP ...
'Blazing a new trail' | Eli Lilly to invest up to $250 million in expanded partnership with Purdue
The investment over the next eight years could be the largest ever industry-academic agreement of its kind in the U.S., the ...
Eli Lilly sales soar 45% on weight loss drug demand, but drugmaker cuts profit outlook after cancer treatment deal
Eli Lilly said sales of weight loss drug Zepbound and diabetes treatment Mounjaro surged in the first quarter.
These Stocks Are Moving the Most Today: Amazon, Nvidia, Tesla, Alibaba, Eli Lilly, Pfizer, NRG Energy, Newmont, and More
Amazon.com, Nvidia, Tesla, and the rest of the Magnificent Seven stocks jump as the U.S. and China reach an agreement to ...